Antibacterial Effect of Ethanolic Extracts of <i>Dodonaea viscosa</i> L. Jacq. and <i>Mammea americana</i> L. against Staphylococci Isolated from Skin Lesions

Pérez-Narváez, Oscar Alberto; Castillo Hernández S, Sandra Loruhama; Leos-Rivas, Catalina; Pérez-Hernández, Raymundo Alejandro; Chávez-Montes, Abelardo; Verduzco-Martínez, Jorge Armando; Sánchez-García, Eduardo

doi:https://doi.org/10.1155/2023/5584412

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2023 | Article ID 5584412 | https://doi.org/10.1155/2023/5584412

Antibacterial Effect of Ethanolic Extracts of Dodonaea viscosa L. Jacq. and Mammea americana L. against Staphylococci Isolated from Skin Lesions

Oscar Alberto Pérez-Narváez,¹Sandra Loruhama Castillo Hernández S,²Catalina Leos-Rivas,¹Raymundo Alejandro Pérez-Hernández,¹Abelardo Chávez-Montes,¹Jorge Armando Verduzco-Martínez,³and Eduardo Sánchez-García¹

Academic Editor: Rahul Shivahare

Received18 Jan 2023

Revised30 Jun 2023

Accepted22 Aug 2023

Published04 Sept 2023

Abstract

Background. The resistance to antibiotics shown by some dermatological pathogenic microorganisms has increased the interest of pharmaceutical and cosmetic industries in developing natural products that possess different biological activities, including antimicrobial effects. Methods. In the present investigation, the antibacterial activity of ethanolic extracts of Dodonaea viscosa aerial part and Mammea americana leaves and seed was evaluated against resistant strains of Staphylococcus isolated from skin lesions and against S. aureus ATCC 25923 (reference strain). Column chromatography (CC) and preparative thin-layer chromatography (PTLC) were used to obtain separate fractions of the seed extract of M. americana. We also determined the antimicrobial resistance of the strains against antibiotics using the agar disc diffusion assay. In addition, phytochemical screening was performed by colorimetric standard techniques. Results. M. americana seed extract showed the highest antibacterial activity with MBC from 2.3 μg/mL to 19.5 μg/mL without differences with gentamicin (). The isolated strain S. epidermidis I showed the highest antimicrobial resistance against the tested antibiotics. PTLC-fractions of M. americana seed extract showed MBC from 3.2 μg/mL to 40.7 μg/mL against S. epidermidis I and S. aureus 25923 (reference), respectively, which suggests a synergistic effect of the secondary metabolites present in the crude ethanolic extract compared to its active PTLC-fractions, where only coumarins and compounds with lactone groups were detected in the phytochemical screening. Conclusion. M. americana seed extract has promising effects that should be considered in further studies as an alternative or adjuvant in treating skin infections caused by staphylococci.

1. Introduction

Human skin is the body’s most extensive organ; it has an average surface area of 2 m² in adults and a variable chemical constitution. Its functions include protection, permeability, and stabilization of body temperature [1]. Skin diseases affect about 900 million people of all ages [2], and although their mortality rate is relatively low, they are often persistent and challenging to treat [1, 3]. According to the Global Burden of Disease (GBD), an estimated 66,500 deaths yearly are due to bacterial infections in this organ [2]. The inappropriate use of antibiotics has favored the appearance of antibiotic-resistant microorganisms, making it difficult to combat the diseases they cause [4]. Due to this and the possible side effects of conventional treatments [5], in recent years, there has been an increased interest in natural products by both the pharmaceutical and cosmetic industries in the search for new, safe, and more effective treatments [6], among which are the antimicrobial and antioxidant properties of plants [7]. The secondary metabolites, synthesized by plants [8], could provide beneficial effects on skin health [9]; such products have been accepted for generations due to their efficacy, biodegradability, low environmental impact, and the fact that, when used in appropriate doses, they do not generate harmful effects [6]. For these reasons, developing new antimicrobial plant products as auxiliaries in treating skin infections is a growing trend [4]. Antimicrobial properties of D. viscosa and M. americana have been previously reported. Regarding this, a significant number of reports highlight the biological activities of M. americana, such as potential source of natural antioxidants, antimicrobial and even for the treatment of skin diseases [10, 11]). Furthermore, a recent study by Pajaro-Gonzalez et al. [12] reported antibacterial activity at low concentrations of the ethanol extract of the seeds of M. americana against S. aureus (ATCC and clinical) strains that are sensitive and resistant to methicillin. Regarding D. viscosa, several reports of its antibacterial activity can be found in the literature. Getie et al. [13] report that D. viscosa, possess antibacterial activity against S. aureus, suggesting the potential of this plant to treat bacterial infections of the skin. Similarly, Mothana et al. [14] mention that D. viscosa, could be a source for antibacterial drugs against gram-positive bacteria, especially against multiresistant microorganisms. In the present study, we evaluated the antibacterial activity of ethanolic extracts of D. viscosa aerial part, and M. americana leaves and seed against Staphylococcus strains isolated from skin lesions and S. aureus ATCC 25923. Besides, the antibacterial activity of fractions obtained by column chromatography and PTLC of M. americana seed extract was also evaluated.

2. Materials and Methods

2.1. Plant Material

D. viscosa was collected in Durango, México, and M. americana in Quintana Roo, México. The plant material was dried at room temperature in the shade; afterward, the leaves of D. viscosa and the aerial part and seeds of M. americana were separated. Each plant sample was crushed and pulverized in a manual grain mill. The dried and ground plants were stored in manila paper envelopes and in a fresh and dry place [15].

2.2. Preparation of Extracts

For extract preparation, 100 g of dry plant material was weighed on an analytical balance (Nimbus® NBL-214e). Plant material was placed in 1,000 mL Erlenmeyer flasks, to which 500 mL of absolute ethanol (CTR Scientific) was added. Maceration was performed by constant agitation in an orbital shaker (Luzeren® THZ-100) at room temperature for 24 h. Subsequently, the extracts were filtered through filter paper (WHATMAN No.1); the solvent recovered was evaporated using a rotary evaporator (Yamato BM 100) under reduced pressure. Finally, the dried extracts were stored in light-protected vials at 4°C until use [16].

2.3. Bacterial Strains and Culture Conditions

Bacterial strains used in this investigation (five strains of S. epidermidis, one strain of S. saprophyticus, and one strain of S. aureus) were obtained from the culture collection of the Analytical Chemistry Laboratory of the Faculty of Biological Sciences. These strains were previously isolated from skin lesions during an independent investigation, carried out from April to June 2018. S. aureus ATCC 25923 was used as a reference. All strains were maintained in tubes with Mueller-Hinton Agar slants (DIFCO) at 4°C until use. Before the antimicrobial assay, active cultures were obtained by inoculating a loopful of each strain into 5 mL of Mueller-Hinton Broth (DIFCO) and incubated overnight at 35°C ±2°C [15].

2.4. Antibiotic Susceptibility Assay

Bacterial susceptibility was evaluated by the agar disc diffusion assay, according to the Kirby-Bauer technique and following the standards established by the Clinical and Laboratory Standards Institute (CLSI). For these, activated cultures were seeded by extension in MH agar plates; subsequently, discs containing antibiotics (MultiBac I.D.) were placed on the agar plate and incubated at 35°C ±2°C for 16 h to 18 h. Finally, the measurement of inhibition zones (mm) was determined and recorded [17]. Antibiotics used were ampicillin (AM) 10 μg, cephalothin (CF) 30 μg, cefoxitin (CFX) 30 μg, ciprofloxacin (CPF) 5 μg, clindamycin (CLM) 30 μg, dicloxacillin (DC) 1 μg, erythromycin (E) 15 μg, gentamicin (GE) 10 μg, penicillin (P) 10 U, sulfamethoxazole+trimethoprim (SXT) 25 μg, tetracycline (T) 30 μg, and vancomycin (V) 30 μg (Multibac Investigación Diagnóstica I.D. Gram positives).

2.5. Agar Well Diffusion Assay

The antimicrobial activity of extracts was determined by the agar well diffusion technique. Each strain was spread using a Digralsky loop onto MH agar plates. Then, wells were cut on the agar using an inverted sterile tube (Ø =8 mm in diameter). Subsequently, 100 μL of the extracts were deposited in each well; ethanol was evaluated alone as a control. Plates were incubated overnight at 35°C ±2°C, and after the incubation period, inhibition zones were recorded. This assay was performed three times in triplicate [18].

2.6. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The microplate dilution technique was used for MIC determination. For this, different concentrations of the extracts were evaluated in MH broth inoculated with 1% of the bacterial strain [19]. Plates were incubated for 18 h at 35°C ±2°C. The MIC value was determined as the concentration of the extract resulting in complete inhibition of visible growth of the microorganisms evaluated. For MBC, an aliquot of 25 μL was taken from each well without visible growth. Subsequently, drops were dispensed onto an MH agar plate [20]. Plates were incubated under previously established conditions. MBC was defined as the concentration of extracts that eliminated 99.9% of the microorganisms evaluated [21].

2.7. Phytochemical Screening

Standard phytochemical tests (Supplementary materials (available here)) to detect metabolites such as carbohydrates, sterols, triterpenes, sesquiterpenes, lactones, tannins, alkaloids, flavonoids, coumarins, quinones, and saponins were performed following standard procedures [22].

2.8. Chromatographic Separation

The extract with the highest antibacterial activity was fractionated by column chromatography (CC) using silica gel 60 Ä (Merck®). The extract was eluted with 1 L of the solvent system CHCl₃-MeOH in different proportions. Fifty-mL portions were collected in 250 mL beakers, and the obtained fractions were concentrated by reduced pressure and resuspended in ethanol (EtOH). The purity of fractions was evaluated using thin-layer chromatography (TLC) [23].

2.9. Detection and Semipurification of Antimicrobial Compounds

The bioautography technique was used to detect the active compounds of the fractions obtained by CC. Developed TLC plates were placed face down inside the MH agar plates with the microorganism of interest previously seeded by extension. Plates were incubated at 35°C ±2°C for 24 h to enable the compounds’ diffusion. Subsequently, fractions with antimicrobial activity were evidenced by the presence of inhibition zones on the agar surface, corresponding to the antimicrobial compound. Retention factors (Rf) were recorded for further analysis. Finally, active compounds were obtained using preparative thin-layer chromatography (PTLC) by scarping plates eluted as bioautography and according to the RF obtained in the bioautography technique [24, 25].

2.10. Statistical Analysis

Data were reported as and were analyzed by ANOVA with Tukey and Dunnett’s test. It has statistical significance .

3. Results and Discussion

3.1. Preliminary Inhibitory Effect of Ethanolic Extracts

The antibacterial properties of plant extracts have been demonstrated in a wide variety of studies. [7, 26, 27]. The present investigation observed such activity in the ethanolic extracts of M. americana and D. viscosa. Both extracts showed inhibition zones (IZ) from 12.5 mm to 30.5 mm against the Staphylococcus strains. The activity of the M. americana seed extract is outstanding since it produced the highest inhibition effect, ranging from 21.3 mm (S. aureus ATCC 25923) to 30.5 mm (S. epidermidis I) and because no significant differences were observed with the positive control (gentamycin). M. americana aerial part extract was less active showing inhibition zones from 15.2 mm (S, saprophyticus) to 22.5 mm (S. aureus) (Table 1). Similar results were reported by Poojary et al. [28] using different extracts of M. suriga root bark against S. aureus ATCC 25923 ( mm-33 mm), attributing this effect to the alkaloids and flavonoids found in the extracts. Likewise, the inhibition zones generated by our M. americana seed extract were similar to the inhibition zones of two hydroxycoumarin isolated from M. africana named Mammea B/BB, and Mammea B/BA which showed inhibition zones of 15 mm and 18 mm, respectively, against S. aureus ATCC 6538 [29].

Regarding the D. viscosa leaf extract against Staphylococcus strains, the inhibition zones showed ranges from 12.5 mm (S. saprophyticus) to 18.8 mm (S. aureus), and significant differences were found with the extracts of M. americana as well as with the positive control (Table 1). However, these results showed superior activity to those reported by Getie et al. [30]. They reported that the methanolic extract of D. viscosa showed inhibition zones of 8 mm to 9 mm against S. aureus ATCC 29213. Al-Haj et al. [31] reported inhibition zones of 16.3 mm against S. aureus, similar to those obtained in this investigation. Mothana et al. [32] reported the effect of aqueous and methanolic extracts of D. viscosa against S. aureus ATCC 6538, showing inhibition zones of 14 mm and 15 mm, respectively. Furthermore, methanolic extract was effective against multidrug-resistant S. aureus from northern Germany ( mm) and against multidrug-resistant S. epidermidis 847 ( mm). Likewise, Monreal [33] reported that the 80% ethanolic extract of D. viscosa presented inhibition zones of 10-20 mm against S. aureus INDRE-LIBM-01001.

3.2. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The MIC values obtained in this work range from 1.7 μg/mL to 1,800 μg/mL, depending on the extract and the strain tested (Table 2). M. americana seed extract showed the lowest MIC against the strains of S. epidermidis and S. saprophyticus with values from 1.7 μg/mL to 2.9 μg/mL. Moreover, the MIC obtained for S. aureus (isolated from skin) was 8.8 μg/mL and 17.0 μg/mL against S. aureus ATCC 25923. Similarly, low MICs were reported by Pajaro-Gonzalez et al. [12], with MIC₉₀ values between 2 μg/mL and 4 μg/mL of the ethanol extract of the seeds of M. americana against S. aureus strains. However, all the results mentioned above are lower than those obtained by Yasunaka et al. [34] who reported 64 μg/mL of methanolic extracts of the seed of M. americana against methicillin-resistant S. aureus strains.

D. viscosa extract showed higher MIC values from 200 μg/mL to 960 μg/mL, according to the tested strain. Similarly, Verotta et al. [35] reported ranges from 125 μg/mL to 1,000 μg/mL against S. aureus ATCC 25923. However, our results are lower than those obtained by Al-Haj et al. [31], who obtained a MIC of 20,000 μg/mL with the methanolic extract of D. viscosa against S. aureus.

The results of MBC (Table 2) show that M. americana seed extract presented the lowest values, ranging from 2.3 μg/mL (S. epidermidis IV strain) to 19.5 μg/mL (S. aureus ATCC 25923). The MBC reported in this research are lower than those found in the literature. Manjulatha [36] mentioned an MBC ranging from 125 μg/mL to 500 μg/mL using the ethanolic seed extracts of M. americana against Streptococcus mutans ATCC 25175 (gram-positive bacteria). Similarly, Pajaro-Gonzalez et al. [12] report MBC higher than 64 μg/mL (>64 μg/mL) establishing in their investigation a bacteriostatic effect of the extract. Interestingly, the ethanolic extract of the aerial part of M. americana presented greater activity against S. epidermidis strains (91 μg/mL to 540 μg/mL) followed by the MBC of isolated and ATCC strains of S. aureus (625 μg/mL and 650 μg/mL, respectively) and finally by S. saprophyticus (1750 μg/mL). On the other hand, we consider that the D. viscosa extract was the least active against staph strains, since four strains presented CMB greater than 1000 μg/mL and two strains are above 700 μg/mL. However, Herrera et al. [37] report MBCs ranging from 20,000 μg/mL to 40,000 μg/mL against S. aureus strains, using 80% ethanol and diethyl ether extracts of D. viscosa leaves, results that are higher than those reported in this investigation.

3.3. Antimicrobial Determination of Isolated PTLC Fractions

Phytochemicals can be antimicrobial when MIC values range from 100 μg/mL to 1,000 μg/mL [38]. Our results show that secondary metabolites are present in the ethanolic seed extract and the isolated PTLC-fractions of M. americana are promising. Two isolated PTLC-fractions showed antimicrobial activity and presented MIC values of 1.8 μg/mL (PTLC fraction II) and 5.6 μg/mL (PTLC fraction I) against S. epidermidis I strain. MIC values for S. aureus ATCC 25923 were 7.7 μg/mL (PTLC fraction II) and 36.1 μg/mL (PTLC fraction I), it was determined that the fraction with the highest antimicrobial activity is fraction II (Table 3). S. epidermidis I strain and S. aureus ATCC 25923 were selected for antimicrobial determination of PTLC fractions because they are the lowest and highest antibacterial sensitivity strains (Table 4). Interestingly, the PTLC-fraction II eluted using a mixture of CHCl₃:MeOH (9.5 : 0.5) presented a similar MIC to the M. americana ethanolic seed extract against the same strain of S. epidermidis I, suggesting this effect is due to the coumarins since these compounds were only detected with the Baljet test for lactones in the phytochemical screening (Table 5). More than 1,800 natural coumarins are known, and many have been evidenced to possess high biological activity [39]. In this sense, our MIC results for the PTLC-fractions of the M. americana seed extract may be comparable with MICs reported by Verotta et al. [40], with Mesua ferrea extract, mesuol compound, and coumarin mixtures against multidrug-resistant S. epidermidis 3112. Liu et al. [40] reported MICs of 2 μg/mL against one strain of S. epidermidis and 4 μg/mL against two strains of S. aureus, using the extract of M. ferrea. It should be mentioned that the MICs reported for the mesuol compound were the same than those obtained with the crude extract (2 μg/mL and 4 μg/mL), which is comparable with the results obtained in this investigation with PTLC fraction II and the ethanolic extract of M. americana. Finally, the extract of M. ferrea and the mesuol compound did not show activity against S. saprophyticus strains.

In addition, MIC for PTLC fraction II (7.7 μg/mL) against S. aureus ATCC 25923 are comparable with the results reported by Yasunaka et al. [34]; they reported MICs values from 1 μg/mL to 8 μg/mL using two flavonoids isolated from the leaf of Calophyllum brasiliense and the fruit skin of M. americana named Mammea A/BA and Mammea A/AA, against methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) strains of S. aureus. Besides this, El-Seedi [41] determined the MIC of the isolated coumarins asphodelin A 4-O-β-D-glucoside and its aglycone asphodelin A isolated from Asphodelus microcarpus and reported 128 μg/mL and 16 μg/mL, respectively, against S. aureus IAM1011. It is essential to mention that synthetic coumarin compounds have shown relevant results, such as those observed by Simões et al. [39], with seventy coumarin compounds from antibiotic novobiocin linked to a pyrazole ring against S. aureus ATCC 12600; the MIC obtained using these synthetic compounds ranged from 0.5 μg/mL to 128 μg/mL. Those results can be compared with the obtained with PTLC-fraction I ( μg/mL) and PTLC-fraction II ( μg/mL) against S. aureus ATCC 25923 (Table 3). MICs and MBCs of the PTLC-fractions suggest a synergistic effect from the M. americana seed extract; the PTLC-fraction II, on the other hand, required almost half the concentration to inhibit S. aureus ATCC 25923, suggesting these metabolites possess a more significant antibacterial effect.

3.4. Phytochemical Screening

There is a wide variety of polyphenols with antimicrobial properties [27]. The antibacterial effect of our extracts can be due to the presence of different phenolic compounds whose biological activities are related to their molecular structures containing hydroxyl groups, and phenolic rings bind to proteins and bacterial membranes to form complexes that inhibit bacterial growth [19]. Flavonoids, flavones, and flavonols are phenolic compounds synthesized by plants in response to microbial infections and are generally effective in vitro against a wide range of microorganisms [18]. In our study, these metabolites were detected by standard phytochemical screening (Table 5) and could be the cause of the effective antibacterial activity in the M. americana and D. viscosa extracts. The inhibitory effect of these compounds has been related to the perturbation of membrane permeability and the inhibition of enzymes such as ATPase and phospholipase A2 [42]. Other secondary metabolites found in the extracts were tannins, which are abundant in plants, and their antimicrobial effect against bacteria and fungi has been demonstrated [43]. On the other hand, alkaloids were not detected with Dragendorff’s reagent, which could indicate antimicrobial activities are mainly by phenolic compounds [19]. Saponins were detectable in all the extracts except in M. americana seed; these metabolites can cause membrane rupture, and their hemolytic activity is known [44]. Likewise, coumarins were also revealed; these phenolic substances are benzene fused to α-pyrone rings, many of which possess antimicrobial properties. In the present investigation, we believe coumarins are the principal cause of antibacterial activity in M. americana extracts because >120 coumarins have been identified in Mammea species with insecticidal, antioxidant, anti-HIV, anticancer, antifungal, antibacterial, antimicrobial, and antibiotic effects [34, 40, 45, 46].

3.5. Antimicrobial-Resistant Profile

Antibiotic resistance has increased in recent years due to the inappropriate use of these drugs and is a severe health problem worldwide [17]. In our study, we observed penicillin and ampicillin insensitivity in isolated strains. It is worth mentioning that the S. epidermidis I strain showed the lowest sensitivity against the gram-positive antimicrobials (Table 4). Likewise, S. epidermidis I, S. epidermidis IV, and S. epidermidis V isolated strains showed multiresistance by presenting insensitivity to four antibiotics [47]. Velásquez et al. [48] determined the antimicrobial profile of 101 isolates of the Staphylococcus genus and observed strains that were resistant to 9 antibiotics. Furthermore, coagulase-negative staphylococci showed resistance to penicillin, ampicillin, erythromycin, tetracycline, kanamycin, and clindamycin. In our work, isolated S. aureus showed intermediate insensitivity to dicloxacillin, whereas the S. epidermidis from our isolated coagulase-negative staphylococci strain was insensitive to gentamicin. Velásquez et al. [48] observed sulfamethoxazole-trimethoprim insensitivity in one strain of S. aureus, whereas coagulase-negative staphylococci did not show resistance; in contrast, we observed resistance in S. epidermidis I, similarly with the work of Liu et al. [40], who reported insensitivity in a strain of S. epidermidis, as well as to erythromycin and gentamicin. Regarding ciprofloxacin, the strain S. epidermidis I showed intermediate resistance, comparable to the one reported by Silva et al. [47]; they observed high susceptibility in coagulase-negative staphylococci isolated from infected chronic wounds. Likewise, we observed similarities in sensitivity to tetracycline except in S. epidermidis I. This resistance is probably a consequence of inappropriate antibiotic use, such as erythromycin, which is widely used to treat staphylococcal infection [49]. We observed resistance to clindamycin in strains that also showed insensitivity to erythromycin, so cross-resistance should be considered. Isolated strains in this work were sensitive to vancomycin, which agrees with Peixoto et al. [50], who mention that vancomycin has become the first-line therapy for most infections caused by methicillin-resistant staphylococci. It is well known that resistance to antibiotics by pathogenic microorganisms hinders the treatment of diseases [4]. In the case of infected skin wounds, healing is difficult [47], which may result in other inconveniences, such as increased treatment costs, hospitalization, and side effects [5].

4. Conclusion

Ethanolic extracts of D. viscosa leaf and M. americana aerial part and seed showed good antibacterial activity against staphylococci isolated from skin lesions. The M. americana seed extract was the most outstanding due to its low MIC/MBC, comparable with the gentamicin effect. The bioactive PTLC-fractions from the seed extract against the most antimicrobial-resistant strain, S. epidermidis I and S. aureus ATCC 25923, suggest a synergistic effect of the extract from which they were obtained. Currently, the use of medicinal plants for the care and treatment of skin infections is of great interest, and therefore, the search for alternatives to face such resistance is relevant.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interest.

Authors’ Contributions

Oscar Alberto Pérez Narváez did the writing, which includes the original draft, and investigation. Sandra Loruhama Castillo Hernández did the strain isolation and general review. Catalina Leos Rivas carried out the review and methodology. Abelardo Chávez-Montes was responsible for the general review and methodology. Jorge Armando Verduzco Martínez worked on the review and validation. Eduardo Sánchez García was in charge of the supervision, review, editing, and correspondence.

Acknowledgments

The authors acknowledge Programa de Apoyo a la Investigación Científica y Tecnológica (PAICYT, UANL SA834-19) for funding our research and Consejo Nacional de Ciencia y Tecnología (CONACYT), for the Postgraduate Scholarship (No. 722125). M.C. Sergio García González, Facultad de Ciencias Biológicas, is acknowledged for his experience and teaching. Dr. David Gilberto García is acknowledged for his support with the Multidiscs for antimicrobial susceptibility.

Supplementary Materials

Standard methods for phytochemical screening. (Supplementary Materials)

References

A. M. Abbasi, M. A. Khan, M. Ahmad, M. Zafar, S. Jahan, and S. Sultana, “Ethnopharmacological application of medicinal plants to cure skin diseases and in folk cosmetics among the tribal communities of North-West Frontier Province, Pakistan,” Journal of Ethnopharmacology, vol. 128, no. 2, pp. 322–335, 2010.
View at: Publisher Site | Google Scholar
R. J. Hay, N. E. Johns, H. C. Williams et al., “The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions,” The Journal of Investigative Dermatology, vol. 134, no. 6, pp. 1527–1534, 2014.
View at: Publisher Site | Google Scholar
N. Lall and N. Kishore, “Are plants used for skin care in South Africa fully explored?” Ethnopharmacology, vol. 153, no. 1, pp. 61–84, 2014.
View at: Publisher Site | Google Scholar
S. Weckesser, K. Engel, B. Simon-Haarhaus, A. Wittmer, K. Pelz, and C. M. Schempp, “Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance,” Phytomedicine, vol. 14, no. 7-8, pp. 508–516, 2007.
View at: Publisher Site | Google Scholar
W. Devi, “Traditional medicinal plants used for various skin diseases and cosmeceuticals in Manipur, North-East India,” in M: medicinal plants and its therapeutic uses, pp. 1–16, OMICS group eBooks, 731 Gull Ave, Foster City, US, 2017.
View at: Google Scholar
J. Contreras, Evaluación de la actividad antioxidante y el efecto citotóxico de los extractos etanólicos, etéreos y fracciones de las inflorescencias y hojas de Achyrocline bogotensis (Kunth) DC (Asteraceae), [Bachelor's thesis], Facultad de Ciencias y Educación, Universidad de Ciencias Aplicadas y Ambientales, Colombia, 2015.
O. A. Pérez Narváez, C. Leos Rivas, C. Rivas Morales, L. Villarreal Treviño, M. P. Barrón González, and E. Sánchez García, “Actividad antimicrobiana y antioxidante de extractos etanólicos de hoja de Arbutus xalapensis Kunt, Mimosa malacophylla Gray y Teucrium cubense Jacquin,” Rev Tendencias en Docencia e Investig en Química, vol. 5, pp. 739–747, 2019.
View at: Google Scholar
S. Gómez, S. Borrego, P. Lavin et al., “Productos ambientalmente amigables de origen vegetal empleados en el control de microorganismos intervinientes en el biodeterioro del patrimonio cultural,” in VII Congreso de Medio Ambiente Mayo 22-24, pp. 1–24, La Plata, Arg, 2012.
View at: Google Scholar
A. Saikia, V. Ryakala, P. Sharma, P. Goswami, and U. Bora, “Ethnobotany of medicinal plants used by Assamese people for various skin ailments and cosmetics,” Journal of Ethnopharmacology, vol. 106, no. 2, pp. 149–157, 2006.
View at: Publisher Site | Google Scholar
C. Lemus, J. Smith-Ravin, and O. Marcelin, “Mammea americana: a review of traditional uses, phytochemistry and biological activities,” Journal of Herbal Medicine, vol. 29, article 100466, 2021.
View at: Publisher Site | Google Scholar
L. G. B. Lima, J. Montenegro, J. P. D. Abreu et al., “Metabolite profiling by UPLC-MSE, NMR, and antioxidant properties of amazonian fruits: mamey apple (mammea americana), camapu (physalis angulata), and uxi (endopleura uchi),” Molecules, vol. 25, no. 2, p. 342, 2020.
View at: Publisher Site | Google Scholar
Y. Pájaro-González, A. F. Oliveros-Díaz, J. Cabrera-Barraza et al., “Mammea B/BA isolated from the seeds of Mammea americana L.(Calophyllaceae) is a potent inhibitor of methicillin-resistant Staphylococcus aureus,” Frontiers in Pharmacology, vol. 13, article 826404, 2022.
View at: Google Scholar
M. Getie, T. Gebre-Mariam, R. Rietz et al., “Evaluation of the anti-microbial and anti-inflammatory activities of the medicinal plants Dodonaea viscosa, Rumex nervosus and Rumex abyssinicus,” Fitoterapia, vol. 74, no. 1-2, pp. 139–143, 2003.
View at: Publisher Site | Google Scholar
R. A. Mothana, S. A. Abdo, S. Hasson, F. Althawab, S. A. Alaghbari, and U. Lindequist, “Antimicrobial, antioxidant and cytotoxic activities and phytochemical screening of some yemeni medicinal plants,” Evidence-based Complementary and Alternative Medicine, vol. 7, no. 3, Article ID 419579, 8 pages, 2010.
View at: Publisher Site | Google Scholar
O. A. Pérez-Narváez, Efecto antioxidante y citoprotector de extractos de plantas con actividad antimicrobiana, [M.S. thesis], Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, México, 2018.
A. Jara, Analisis fitoquímico y determinación de la actividad antioxidante del extracto etanólico de las hojas de la especie Piper imperiale (Piperaceae), [Bachelor's thesis], Facultad de Ciencia y Tecnología Química, Universidad de Ciencias Aplicadas y Ambientales, Colombia, 2013.
I. Mahmoud, K. Altaif, M. Abu Sini, S. Daoud, and N. Aqel, “Determination of antimicrobial drug resistance among bacterial isolates in two hospitals of Baghdad,” Jordan Journal of Pharmaceutical Sciences, vol. 13, no. 1, pp. 1–8, 2020.
View at: Google Scholar
K. Das, R. Tiwari, and D. Shrivastava, “Techniques for evaluating medicinal plant products as antimicrobial agents: current methods and future trends,” Journal of Medicinal Plants Research, vol. 4, no. 2, pp. 104–111, 2010.
View at: Google Scholar
Z. Cheikna, A. Savadogo, M. Somda, J. Koudou, and A. S. Traore, “In vitro evaluation of the antimicrobial and antioxidant properties of extracts from whole-plant of Alternanthera pungens H.B. & K. and leaves of Combretum sericeum G. Don,” International Journal of Phytomedicine, vol. 3, no. 2, pp. 182–191, 2011.
View at: Google Scholar
A. Miles, S. Misra, and J. O. Irwin, “The estimation of the bactericidal power of the blood,” Epidemiology & Infection, vol. 38, no. 6, pp. 732–749, 1938.
View at: Publisher Site | Google Scholar
C. A. S. Tirloni, L. F. B. Macorini, U. P. dos Santos et al., “Evaluation of the antioxidant activity, antimicrobial effect, and acute toxicity from leaves of Allophylus edulis (a. St.-Hil., A. Juss. Cambess &.) Hieron. Ex Niederl,” African Journal of Pharmacy and Pharmacology, vol. 9, no. 11, pp. 353–362, 2015.
View at: Google Scholar
M. J. Verde-Star, S. García-González, and C. Rivas-Morales, “Metodología científica para el estudio de plantas medicinales,” in Investigación en plantas de importancia médica, C. Rivas-Morales, M. A. Oranday-Cardenas, and M. J. Verde-Star, Eds., pp. 1–40, OmniaScience, Barcelona, 2016.
View at: Publisher Site | Google Scholar
W. Cardona, S. Robledo, B. Rojano et al., “Actividad leishmanicida y antioxidante de extractos de Piper daniel-gonzalezii Trel. (Piperaceae),” Revista Cubana de Plantas Medicinales, vol. 18, no. 2, pp. 268–277, 2013.
View at: Google Scholar
A. Lizcano and J. Vergara, Evaluation of the antimicrobial activity of the ethanolic extracts and/or essential oils of the plant species Valeriana pilosa, Hesperomeles ferruginea, Myrcianthes rhopaloides and Passiflora manicata against pathogenic and phytopathogenic microorganisms, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia, 2008.
A. L. Ramirez and B. H. Diaz, “Actividad antimicrobiana de extractos y fracciones del ruibarbo (Rumez conglomeratus),” Scientia et Technica, vol. 13, no. 33, pp. 397–400, 2007.
View at: Google Scholar
L. Pozzo, R. Russo, S. Frassinetti et al., “Wild Italian Prunus spinosa L. fruit exerts in vitro antimicrobial activity and protects against in vitro and in vivo oxidative stress,” Food, vol. 9, no. 1, pp. 1–15, 2020.
View at: Publisher Site | Google Scholar
A. Bouyahya, N. Moussaoui, J. Abrini, Y. Bakri, and N. Dakka, “Determination of phenolic contents, antioxidant and antibacterial activities of strawberry tree (Arbutus unedo L.) leaf extract,” British Biotechnology Journal, vol. 14, no. 3, pp. 1–10, 2016.
View at: Publisher Site | Google Scholar
M. Poojary, K. Vishnumurthy, and A. V. Adhikari, “Extraction, characterization, and biological studies of phytochemicals from Mammea suriga,” Journal of Pharmaceutical Analysis, vol. 5, no. 3, pp. 182–189, 2015.
View at: Publisher Site | Google Scholar
B. M. W. Ouahouo, A. G. B. Azebaze, M. Meyer, B. Bodo, Z. T. Fomum, and A. E. Nkengfack, “Cytotoxic and antimicrobial coumarins from Mammea africana,” Annals of Tropical Medicine and Parasitology, vol. 98, no. 7, pp. 733–739, 2004.
View at: Publisher Site | Google Scholar
M. Getie, T. Gebre-Mariam, R. Rietz et al., “Evaluation of the anti-microbial and anti-inflammatory activities of the medicinal plants Dodonaea viscosa, Rumex nervosus, and Rumex abyssinicus,” Fitoterapia, vol. 74, no. 1-2, pp. 139–143, 2003.
View at: Publisher Site | Google Scholar
N. Al-Haj, A. Reem, H. Al-Shamahy, K. Al-Moyed, S. S. Bahaj, and A. Jaber, “Antimicrobial activity of five Yemeni medicinal plants against selected human pathogenic bacteria and fungi,” American Journal of Plant Sciences, vol. 10, no. 10, pp. 1699–1707, 2019.
View at: Publisher Site | Google Scholar
R. A. A. Mothana, S. A. A. Abdo, S. Hasson, F. M. N. Althawab, S. A. Z. Alaghbari, and U. Lindequist, “Antimicrobial, antioxidant and cytotoxic activities and phytochemical screening of some Yemeni medicinal plants,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, Article ID 419579, 8 pages, 2010.
View at: Publisher Site | Google Scholar
H. Monreal, Compuestos fenólicos y la actividad biologica de tres especies de plantas silvestres del estado de Durago, México (Fouquieria splendens, Dodonaea viscosa y Physalis angulata), [M.S. thesis], Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, Instituto Politécnico Nacional, México, 2015.
K. Yasunaka, F. Abe, A. Nagayama et al., “Antibacterial activity of crude extracts from Mexican medicinal plants and purified coumarins and xanthones,” Journal of Ethnopharmacology, vol. 97, no. 2, pp. 293–299, 2005.
View at: Publisher Site | Google Scholar
L. Verotta, E. Lovaglio, G. Vidari et al., “4-alkyl- and 4-phenylcoumarins from Mesua ferrea as promising multidrug-resistant antibacterials,” Phytochemistry, vol. 65, no. 21, pp. 2867–2879, 2004.
View at: Publisher Site | Google Scholar
K. Manjulatha, “A Comparative Study of Different Parts of the Flavonoid-Rich Plant,” in Dodonaea viscosa for antimicrobial and antioxidant potential, LAP Lambert Academic Publishing, Germany, 2012.
View at: Google Scholar
A. H. Herrera, L. F. Ospina, L. Fang, and A. Díaz Caballero, “Susceptibility of Porphyromonas gingivalis and Streptococcus mutans to antibacterial effect from Mammea americana,” Advances in Pharmacological Sciences, vol. 2014, Article ID 384815, 6 pages, 2014.
View at: Publisher Site | Google Scholar
Z. A. Esmaeel and K. M. AL-Jobori, “Antimicrobial effect of Dodonaea viscosa jacq extracts against some pathogenic microorganisms,” Iraqi Journal of Science, vol. 52, no. 4, pp. 425–439, 2011.
View at: Google Scholar
M. Simões, R. N. Bennett, and E. A. S. Rosa, “Understanding antimicrobial activities of phytochemicals against multidrug-resistant bacteria and biofilms,” Natural Product Reports, vol. 26, no. 6, pp. 746–757, 2009.
View at: Publisher Site | Google Scholar
H. Liu, Z. L. Ren, W. Wang et al., “Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: design, synthesis and antibacterial activity,” European Journal of Medicinal Chemistry, vol. 157, pp. 81–87, 2018.
View at: Publisher Site | Google Scholar
H. R. El-Seedi, “Antimicrobial arylcoumarins from Asphodelus microcarpus,” Journal of Natural Products, vol. 70, no. 1, pp. 118–120, 2007.
View at: Publisher Site | Google Scholar
D. A. Akinpelu, O. A. Aiyegoro, and A. I. Okoh, “The bioactive potentials of two medicinal plants commonly used as folklore remedies among some tribes in West Africa,” African Journal of Biotechnology, vol. 8, no. 8, pp. 1660–1664, 2009.
View at: Google Scholar
K. Ho, C. Tsai, J. Huang, C. P. Chen, T. C. Lin, and C. C. Lin, “Antimicrobial activity of tannin components from Vaccinium vitis-idaea L,” The Journal of Pharmacy and Pharmacology, vol. 53, no. 2, pp. 187–191, 2001.
View at: Publisher Site | Google Scholar
V. M. A. D. Oliveira, A. L. B. Carneiro, G. S. D. B. Cauper, and A. M. Pohlit, “In vitro screening of Amazonian plants for hemolytic activity and inhibition of platelet aggregation in human blood,” Acta Amaz, vol. 39, no. 4, pp. 973–980, 2009.
View at: Publisher Site | Google Scholar
R. Reyes, E. Estrada, E. Vega, F. Abe, J. Kinjo, and S. Hernández-Ortega, “Trypanocidal constituents in plants. 7. Mammea-type coumarins,” Memórias do Instituto Oswaldo Cruz, vol. 103, no. 5, pp. 431–436, 2008.
View at: Publisher Site | Google Scholar
H. Yang, B. Jiang, K. A. Reynertson, M. J. Basile, and E. J. Kennelly, “Comparative analyses of bioactive mammea coumarins from seven parts of Mammea americana by HPLC-PDA with LC-MS,” Journal of Agricultural and Food Chemistry, vol. 54, no. 12, pp. 4114–4120, 2006.
View at: Publisher Site | Google Scholar
V. Silva, A. Marcoleta, V. Silva et al., “Prevalencia y perfil de susceptibilidad antimicrobiana en bacterias aisladas de úlceras crónicas infectadas en adultos,” Revista chilena de infectología, vol. 35, no. 2, pp. 155–162, 2018.
View at: Publisher Site | Google Scholar
S. D. C. J. Velásquez, L. D. T. Higuera, J. L. P. Arango, J. L. Rodríguez Bautista, F. E. García Castro, and R. E. Patiño Burbano, “Perfil de resistencia antimicrobiana en aislamientos de Staphylococcus spp obtenidos de leche bovina en Colombia,” Revista Argentina de Microbiología, vol. 52, no. 2, pp. 121–130, 2020.
View at: Publisher Site | Google Scholar
N. M. Rojas, N. Fernández, M. H. Espino, and M. D. Fernández Ferrer, “Patrones de drogorresistencia de cepas de Staphylococcus aureus de origen clínico humano,” Revista Cubana de Medicina Tropical, vol. 53, no. 1, pp. 53–58, 2001.
View at: Google Scholar
P. B. Peixoto, F. H. Massinhani, K. R. N. Dos Santos et al., “Methicillin-resistant Staphylococcus epidermidis isolates with reduced vancomycin susceptibility from bloodstream infections in a neonatal intensive care unit,” Journal of Medical Microbiology, vol. 69, no. 1, pp. 41–45, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Oscar Alberto Pérez-Narváez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

495

Downloads

376

Citations